Association of circulating transcriptomic profiles with mortality in sickle cell disease

Ankit A. Desai, Zhengdeng Lei, Neil Bahroos, Mark Maienschein-Cline, Santosh L. Saraf, Xu Zhang, Binal N. Shah, Seyed M. Nouraie, Taimur Abbasi, Amit R. Patel, Roberto M. Lang, Yves Lussier, Joe G.N. Garcia, Victor R. Gordeuk, Roberto F. Machado

Research output: Research - peer-reviewArticle

  • 1 Citations

Abstract

Sickle cell disease (SCD) complications are associated with increased morbidity and risk of mortality. We sought to identify a circulating transcriptomic profile predictive of these poor outcomes in SCD. Training and testing cohorts consisting of adult patients withSCD were recruited and prospectively followed. A pathway-based signature derived from grouping peripheral blood mononuclear cell transcriptomes distinguished 2 patient clusters with differences in survival in the training cohort. These findings were validated in a testing cohort in which the association between cluster 1 molecular profiling and mortality remained significant in a fully adjusted model. In a third cohort of West African children with SCD, cluster 1 differentiated SCD severity using a published scoring index. Finally, a risk score composed of assigning weights to cluster 1 profiling, along with established clinical risk factors using tricuspid regurgitation velocity, white blood cell count, history of acute chest syndrome, and hemoglobin levels, demonstrated a higher hazard ratio for mortality in both the training and testing cohorts compared with clinical risk factors or cluster 1 data alone. Circulating transcriptomic profiles are a powerful method to risk-stratify severity of disease and poor outcomes in both children and adults, respectively, with SCD and highlight potential associated molecular pathways.

LanguageEnglish (US)
Pages3009-3016
Number of pages8
JournalBlood
Volume129
Issue number22
DOIs
StatePublished - Jun 1 2017

Fingerprint

Sickle Cell Anemia
Mortality
Testing
Blood
Acute Chest Syndrome
Tricuspid Valve Insufficiency
Leukocyte Count
Transcriptome
Blood Cells
Hemoglobins
Morbidity
Weights and Measures
Survival
Hazards
Cells

ASJC Scopus subject areas

  • Immunology
  • Biochemistry
  • Hematology
  • Cell Biology

Cite this

Desai, A. A., Lei, Z., Bahroos, N., Maienschein-Cline, M., Saraf, S. L., Zhang, X., ... Machado, R. F. (2017). Association of circulating transcriptomic profiles with mortality in sickle cell disease. Blood, 129(22), 3009-3016. DOI: 10.1182/blood-2016-11-752279

Association of circulating transcriptomic profiles with mortality in sickle cell disease. / Desai, Ankit A.; Lei, Zhengdeng; Bahroos, Neil; Maienschein-Cline, Mark; Saraf, Santosh L.; Zhang, Xu; Shah, Binal N.; Nouraie, Seyed M.; Abbasi, Taimur; Patel, Amit R.; Lang, Roberto M.; Lussier, Yves; Garcia, Joe G.N.; Gordeuk, Victor R.; Machado, Roberto F.

In: Blood, Vol. 129, No. 22, 01.06.2017, p. 3009-3016.

Research output: Research - peer-reviewArticle

Desai, AA, Lei, Z, Bahroos, N, Maienschein-Cline, M, Saraf, SL, Zhang, X, Shah, BN, Nouraie, SM, Abbasi, T, Patel, AR, Lang, RM, Lussier, Y, Garcia, JGN, Gordeuk, VR & Machado, RF 2017, 'Association of circulating transcriptomic profiles with mortality in sickle cell disease' Blood, vol 129, no. 22, pp. 3009-3016. DOI: 10.1182/blood-2016-11-752279
Desai AA, Lei Z, Bahroos N, Maienschein-Cline M, Saraf SL, Zhang X et al. Association of circulating transcriptomic profiles with mortality in sickle cell disease. Blood. 2017 Jun 1;129(22):3009-3016. Available from, DOI: 10.1182/blood-2016-11-752279
Desai, Ankit A. ; Lei, Zhengdeng ; Bahroos, Neil ; Maienschein-Cline, Mark ; Saraf, Santosh L. ; Zhang, Xu ; Shah, Binal N. ; Nouraie, Seyed M. ; Abbasi, Taimur ; Patel, Amit R. ; Lang, Roberto M. ; Lussier, Yves ; Garcia, Joe G.N. ; Gordeuk, Victor R. ; Machado, Roberto F./ Association of circulating transcriptomic profiles with mortality in sickle cell disease. In: Blood. 2017 ; Vol. 129, No. 22. pp. 3009-3016
@article{1462d85a527b4ab59c77b50f5cb3940c,
title = "Association of circulating transcriptomic profiles with mortality in sickle cell disease",
abstract = "Sickle cell disease (SCD) complications are associated with increased morbidity and risk of mortality. We sought to identify a circulating transcriptomic profile predictive of these poor outcomes in SCD. Training and testing cohorts consisting of adult patients withSCD were recruited and prospectively followed. A pathway-based signature derived from grouping peripheral blood mononuclear cell transcriptomes distinguished 2 patient clusters with differences in survival in the training cohort. These findings were validated in a testing cohort in which the association between cluster 1 molecular profiling and mortality remained significant in a fully adjusted model. In a third cohort of West African children with SCD, cluster 1 differentiated SCD severity using a published scoring index. Finally, a risk score composed of assigning weights to cluster 1 profiling, along with established clinical risk factors using tricuspid regurgitation velocity, white blood cell count, history of acute chest syndrome, and hemoglobin levels, demonstrated a higher hazard ratio for mortality in both the training and testing cohorts compared with clinical risk factors or cluster 1 data alone. Circulating transcriptomic profiles are a powerful method to risk-stratify severity of disease and poor outcomes in both children and adults, respectively, with SCD and highlight potential associated molecular pathways.",
author = "Desai, {Ankit A.} and Zhengdeng Lei and Neil Bahroos and Mark Maienschein-Cline and Saraf, {Santosh L.} and Xu Zhang and Shah, {Binal N.} and Nouraie, {Seyed M.} and Taimur Abbasi and Patel, {Amit R.} and Lang, {Roberto M.} and Yves Lussier and Garcia, {Joe G.N.} and Gordeuk, {Victor R.} and Machado, {Roberto F.}",
year = "2017",
month = "6",
doi = "10.1182/blood-2016-11-752279",
volume = "129",
pages = "3009--3016",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "22",

}

TY - JOUR

T1 - Association of circulating transcriptomic profiles with mortality in sickle cell disease

AU - Desai,Ankit A.

AU - Lei,Zhengdeng

AU - Bahroos,Neil

AU - Maienschein-Cline,Mark

AU - Saraf,Santosh L.

AU - Zhang,Xu

AU - Shah,Binal N.

AU - Nouraie,Seyed M.

AU - Abbasi,Taimur

AU - Patel,Amit R.

AU - Lang,Roberto M.

AU - Lussier,Yves

AU - Garcia,Joe G.N.

AU - Gordeuk,Victor R.

AU - Machado,Roberto F.

PY - 2017/6/1

Y1 - 2017/6/1

N2 - Sickle cell disease (SCD) complications are associated with increased morbidity and risk of mortality. We sought to identify a circulating transcriptomic profile predictive of these poor outcomes in SCD. Training and testing cohorts consisting of adult patients withSCD were recruited and prospectively followed. A pathway-based signature derived from grouping peripheral blood mononuclear cell transcriptomes distinguished 2 patient clusters with differences in survival in the training cohort. These findings were validated in a testing cohort in which the association between cluster 1 molecular profiling and mortality remained significant in a fully adjusted model. In a third cohort of West African children with SCD, cluster 1 differentiated SCD severity using a published scoring index. Finally, a risk score composed of assigning weights to cluster 1 profiling, along with established clinical risk factors using tricuspid regurgitation velocity, white blood cell count, history of acute chest syndrome, and hemoglobin levels, demonstrated a higher hazard ratio for mortality in both the training and testing cohorts compared with clinical risk factors or cluster 1 data alone. Circulating transcriptomic profiles are a powerful method to risk-stratify severity of disease and poor outcomes in both children and adults, respectively, with SCD and highlight potential associated molecular pathways.

AB - Sickle cell disease (SCD) complications are associated with increased morbidity and risk of mortality. We sought to identify a circulating transcriptomic profile predictive of these poor outcomes in SCD. Training and testing cohorts consisting of adult patients withSCD were recruited and prospectively followed. A pathway-based signature derived from grouping peripheral blood mononuclear cell transcriptomes distinguished 2 patient clusters with differences in survival in the training cohort. These findings were validated in a testing cohort in which the association between cluster 1 molecular profiling and mortality remained significant in a fully adjusted model. In a third cohort of West African children with SCD, cluster 1 differentiated SCD severity using a published scoring index. Finally, a risk score composed of assigning weights to cluster 1 profiling, along with established clinical risk factors using tricuspid regurgitation velocity, white blood cell count, history of acute chest syndrome, and hemoglobin levels, demonstrated a higher hazard ratio for mortality in both the training and testing cohorts compared with clinical risk factors or cluster 1 data alone. Circulating transcriptomic profiles are a powerful method to risk-stratify severity of disease and poor outcomes in both children and adults, respectively, with SCD and highlight potential associated molecular pathways.

UR - http://www.scopus.com/inward/record.url?scp=85020247529&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020247529&partnerID=8YFLogxK

U2 - 10.1182/blood-2016-11-752279

DO - 10.1182/blood-2016-11-752279

M3 - Article

VL - 129

SP - 3009

EP - 3016

JO - Blood

T2 - Blood

JF - Blood

SN - 0006-4971

IS - 22

ER -